Current fields of action

REGENERATE is intended to develop a “market place” character functioning as a mediator between research, clinic and industry thereby meeting the demands in the rapidly developing field of Regenerative Medicine and biomaterials. Currently 25 research groups from 8 European countries (Austria, Czech Republic, Germany, Italy, Portugal, The Netherlands, Spain and France) are actively contributing to the activities of the network. These are structured in the various sections of the EEIG ranging from research, educational programmes to regulatory issues and public affairs.

REGENERATE serves as a platform for research projects. Following the adoption of the seventh Framework Programme (FP7) the first calls for proposals have been published on December 22, 2006. Based on these first calls the network as well as individual research groups organised in our network are currently discussing cooperation projects to contribute to the European Research Area.

Strategic partnerships with 9 companies provide a basis for the industrial platform to be enlarged aiming to support the translation of basic science into clinical application. 

The demand for new and intelligent medical products is growing and can be expected to open up new industrial and/or service fields also calling for specific educational programmes like a European Master Programme in Regenerative Medicine as initiated and currently being developed as a postgraduate part-time University Course within the network involving 9 universities from 5 European countries.